Literature DB >> 33184114

Aetiology and incidence of sudden cardiac arrest and death in young competitive athletes in the USA: a 4-year prospective study.

Danielle F Peterson1, Kristen Kucera2, Leah Cox Thomas3, Joseph Maleszewski4, David Siebert5, Martha Lopez-Anderson6, Monica Zigman5, Jared Schattenkerk7, Kimberly G Harmon5, Jonathan A Drezner8.   

Abstract

OBJECTIVE: To investigate the aetiology and incidence of sudden cardiac arrest and death (SCA/D) in US competitive athletes.
METHODS: Prospective surveillance was conducted from 1 July 2014 to 30 June 2018 through the National Center for Catastrophic Sports Injury Research in collaboration with national sports organisations. Autopsy reports, death certificates, and medical records were reviewed by an expert panel to determine aetiology. Athlete participation statistics from the National Federation of State High School Associations and the National Collegiate Athletic Association (NCAA) were used to calculate incidence rates per athlete-years (AY). Comparisons of incidence rates were calculated using incidence rate ratios (IRR) with 95% CIs.
RESULTS: 331 cases of confirmed SCA/D (158 survivors; 173 fatalities) were identified; 15.4% in middle school, 61.6% in high school and 16.6% in college and professional athletes. Average age was 16.7 (11-29) years, and the majority were in male (83.7%), basketball (28.7%) or American football (25.4%) athletes. Common causes included hypertrophic cardiomyopathy (20.6%), idiopathic left ventricular hypertrophy (13.4%), coronary artery anomalies (12.0%) and autopsy-negative sudden unexplained death (9.6%). Coronary anomalies were more common in middle school athletes (28%), while cardiomyopathies (hypertrophic, arrhythmogenic, dilated, non-compaction or restricted) accounted for 47% of cases in college and professional athletes. Incidence was higher in male versus female athletes at the high school (1:43 932 AY (95% CI 1:38 101 to 1:50 907) vs 1:203 786 AY (95% CI 1:145 251 to 1:293 794); IRR 4.6 (95% CI 3.1 to 7.2)) and NCAA (1:34 906 AY (95% CI 1:25 385 to 1:49 173) vs 1:123 278 AY (95% CI 1:66 078 to 1:249 853); IRR 3.5 (95% CI 1.5 to 9.5)) levels. African American male NCAA Division I basketball players had the highest annual incidence rate of SCA/D (1:2087 AY (95% CI 1:1073 to 1:4 450)).
CONCLUSIONS: Cardiomyopathies account for nearly half of SCA/D cases in college and professional athletes, while coronary artery anomalies play a more prominent role than expected in middle school athletes. Over half of SCA cases in athletes result in sudden death, calling for improved prevention strategies. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cardiology; cardiovascular; death; prevention

Year:  2020        PMID: 33184114     DOI: 10.1136/bjsports-2020-102666

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  13 in total

1.  Resuming Training in High-Level Athletes After Mild COVID-19 Infection: A Multicenter Prospective Study (ASCCOVID-19).

Authors:  Laurent Chevalier; Hubert Cochet; Saagar Mahida; Sylvain Blanchard S; Antoine Benard; Tanguy Cariou; Soumaya Sridi-Cheniti; Samy Benhenda; Stéphane Doutreleau; Stéphane Cade; Sylvain Guerard; Jean-Michel Guy; Pascale Trimoulet; Stéphane Picard; Bernard Dusfour; Aurelie Pouzet; Stéphanie Roseng; Marco Franchi; Pierre Jaïs; Isabelle Pellegrin
Journal:  Sports Med Open       Date:  2022-06-25

2.  Screening electrocardiogram in young athletes and military members: a systematic review and meta-analysis.

Authors:  Aaron Lear; Niraj Patel; Chanda Mullen; Marian Simonson; Vince Leone; Constantinos Koshiaris; David Nunan
Journal:  J Athl Train       Date:  2021-05-26       Impact factor: 3.824

3.  Incidence of sudden cardiac arrest and death in young athletes and military members: a systematic review and meta-analysis.

Authors:  Aaron Lear; Niraj Patel; Chanda Mullen; Marian Simonson; Vince Leone; Constantinos Koshiaris; David Nunan
Journal:  J Athl Train       Date:  2021-05-26       Impact factor: 3.824

Review 4.  Diagnostic Workflow in Competitive Athletes with Ventricular Arrhythmias and Suspected Concealed Cardiomyopathies.

Authors:  Maria Lucia Narducci; Michela Cammarano; Valeria Novelli; Antonio Bisignani; Chiara Pavone; Francesco Perna; Gianluigi Bencardino; Gaetano Pinnacchio; Massimiliano Bianco; Paolo Zeppilli; Vincenzo Palmieri; Gemma Pelargonio
Journal:  Medicina (Kaunas)       Date:  2021-02-20       Impact factor: 2.430

Review 5.  Catheter Ablation of Life-Threatening Ventricular Arrhythmias in Athletes.

Authors:  Nicola Tarantino; Domenico G Della Rocca; Nicole S De Leon De La Cruz; Eric D Manheimer; Michele Magnocavallo; Carlo Lavalle; Carola Gianni; Sanghamitra Mohanty; Chintan Trivedi; Amin Al-Ahmad; Rodney P Horton; Mohamed Bassiouny; J David Burkhardt; G Joseph Gallinghouse; Giovanni B Forleo; Luigi Di Biase; Andrea Natale
Journal:  Medicina (Kaunas)       Date:  2021-02-26       Impact factor: 2.430

6.  Cardiovascular involvement among collegiate athletes following COVID-19 infection.

Authors:  Christle C Guevarra; Nicholas Murray; Daniel Cipriani; Kevin Mailland; Amber Char; Kyle Coffman; Cameron Davis; Frank Truong; Alfred Danielian; Glenn Barnes; Wade Gaal
Journal:  J Clin Transl Res       Date:  2022-01-03

7.  Socioeconomic factors and outcomes from exercise-related sudden cardiac arrest in high school student-athletes in the USA.

Authors:  Jared Schattenkerk; Kristen Kucera; Danielle F Peterson; Robert A Huggins; Jonathan A Drezner
Journal:  Br J Sports Med       Date:  2021-10-29       Impact factor: 13.800

Review 8.  Cardiopulmonary Resuscitation and Defibrillator Use in Sports.

Authors:  Mafalda Carrington; Rui Providência; C Anwar A Chahal; Flavio D'Ascenzi; Alberto Cipriani; Fabrizio Ricci; Mohammed Y Khanji
Journal:  Front Cardiovasc Med       Date:  2022-02-15

9.  Rationale and design of the PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes.

Authors:  Ruben De Bosscher; Christophe Dausin; Kristel Janssens; Jan Bogaert; Adrian Elliott; Olivier Ghekiere; Caroline M Van De Heyning; Prashanthan Sanders; Jonathan Kalman; Diane Fatkin; Lieven Herbots; Rik Willems; Hein Heidbuchel; André La Gerche; Guido Claessen
Journal:  BMJ Open Sport Exerc Med       Date:  2022-03-18

10.  Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry.

Authors:  Curt J Daniels; Saurabh Rajpal; Joel T Greenshields; Geoffrey L Rosenthal; Eugene H Chung; Michael Terrin; Jean Jeudy; Scott E Mattson; Ian H Law; James Borchers; Richard Kovacs; Jeffrey Kovan; Sami F Rifat; Jennifer Albrecht; Ana I Bento; Lonnie Albers; David Bernhardt; Carly Day; Suzanne Hecht; Andrew Hipskind; Jeffrey Mjaanes; David Olson; Yvette L Rooks; Emily C Somers; Matthew S Tong; Jeffrey Wisinski; Jason Womack; Carrie Esopenko; Christopher J Kratochvil; Lawrence D Rink
Journal:  JAMA Cardiol       Date:  2021-05-27       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.